摘要
目的:分析当归芍药散治疗慢性盆腔炎的效果。方法:本次对象为我院2011年1月-2014年8月收治的慢性盆腔炎患者220例,随机分成两组。110例对照组采用西药治疗,110例试验组采用当归芍药散治疗,对比两组的治疗结果。结果:试验组控制率为94.5%(104/110),对照组控制率为85.5%(94/110),差异有统计学意义(P <0.05);试验组治疗后半个月、1个月的症状评分分别为(6.92±3.28)分、(1.63±2.05)分,低于对照组的(8.57±4.02)分、(4.18±2.61)分,差异有统计学意义(P <0.05);试验组血流动力学(血沉、红细胞积压、血浆黏度、纤维蛋白原)水平、IL-6和TNF-α水平均低于对照组,差异有统计学意义(P <0.05)。结论:给予慢性盆腔炎患者当归芍药散治疗,能改善血流动力学,提高治疗结果,改善预后,值得推广。
Objective: To analyze the effect of Danggui Shaoyao San (当归芍药散) on chronic pelvic inflammatory disease. Methods: 220 patients were randomly divided into two groups, 110 cases in each. The control group was given western medicine. The experiment group was treated with Danggui Shaoyao San. Results: The control rate was 94.5%(104/110) in the experimental group and 85.5%(94/110) in the control group, with a statistically significant difference (P<0.05). After half a month and one month, the symptoms score in the experiment group were (6.92±3.28) and (1.63±2.05) respectively, lower than (8.57±4.02) and (4.18±2.61) in the control group, with statistically significant differences (P<0.05). The blood flow levels (erythrocyte sedimentation rate, red blood cell accumulation, plasma viscosity, fibrinogen), IL-6 and TNF-α in the experiment group were lower than the control group (P<0.05). Conclusion: Danggui Shaoyao San can improve hemodynamics, treatment outcomes and prognosis, is worth promoting.
出处
《中医临床研究》
2019年第4期48-50,共3页
Clinical Journal Of Chinese Medicine
关键词
慢性盆腔炎
当归芍药散
临床疗效
Chronic pelvic inflammatory disease
Danggui Shaoyao San
Clinical efficacy
